Cancer Treatment Centers of America in Phoenix Incorporates Artificial Intelligence System for Enhanced Colonoscopy Screenings | News

0
225

PHOENIX – (BUSINESS WIRE) – Jan. October 2021 – Cancer Treatment Centers of America® (CTCA) Phoenix becomes the first hospital in the western half of the US and the first Arizona hospital to use GI Genius – a strong ally in the fight against colon cancer powered by artificial intelligence (AI ) Helping Doctors Detect Polyps. This press release contains multimedia. View the full version here: https://www.businesswire.com/news/home/20211028005768/en/ The GI Genius module uses advanced AI software to highlight suspicious polyps with a visual marker in real time. (Photo: Business Wire) The GI Genius module uses advanced AI software to highlight suspicious polyps with a visual marker in real time – and serves as the gastroenterologist’s constantly vigilant second observer with a sensitivity rate per lesion of 99.7%. 1 Studies have shown that AI-assisted colonoscopy can increase the detection rate of polyps, and every 1% increase in adenoma detection rate reduces the risk of colon cancer by 3%. 2,3 Colon cancer is the third most common cancer diagnosed in the United States, with nearly 150,000 new cases annually. 4 Colon cancer rates have increased in patients under the age of 50, and in May of this year the U.S. Task Force on Preventive Services (USPSTF) officially changed its guidelines to start colorectal cancer screening at the age of 45 instead of 50. The new guidelines will prescribe insurance coverage for preventive screenings from October 45+. “This is a game-changing addition to our cancer control arsenal,” said Dr. Toufic Kachaamy, director of the CTCA Enterprise Interventional Program and gastroenterologist at CTCA Phoenix, on GI Genius, the first and only colon polyp detection AI system in the United States. “Early detection is important. With the support of this new system, I, as a physician, will be able to better meet the needs of the patients and communities we serve ”(such as polyps and adenomas) in real time during standard white light endoscopy exams of patients undergoing screening – and undergo surveillance endoscopy of the mucosal examinations. The GI Genius computerized detection device is limited to use with standard white light endoscopic imaging. This device is not intended to be a substitute for clinical decision-making. To help people assess their personal cancer risk, CTCA has developed an online risk assessment tool. The five-minute evaluation provides an instant comprehensive risk assessment for the most common cancers as well as personalized evidence-based screening and lifestyle recommendations. To schedule colon cancer screening at CTCA Phoenix, call 602-883-1463 or visit cancercenter.com/locations/phoenix/departments/gastroenterology to learn more about the GI division at CTCA Phoenix. About Cancer Treatment Centers of America Cancer Treatment Centers of America ® (CTCA) is a national oncology network of hospitals and outpatient care centers that offers an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy, and advances in precision medicine with supportive therapies, to manage side effects and improve quality of life during treatment and survival during treatment. CTCA ® publishes patient outcomes, including patient experience, lifespan, quality of life, patient safety, and quality of care, every six months. CTCA also offers qualified patients a range of clinical trials that can identify new treatment options supported by scientific and experimental research. CTCA patient satisfaction scores are consistently among the highest for any cancer treatment provider in the country. Visit cancercenter.com for more information .———————————————————— 1. Hassan C. et al. New artificial intelligence system: first validation study compared to experienced endoscopists for the detection of colorectal polyps. Colon. 2020; 69 (5): 799-8002. Corley DA et al. Adenoma detection rate and risk of colon cancer and death. N Eng J Med. 2014; 370: 1298-306.3. Repici A, Badalamenti M, Maselli R, et al. Effectiveness of computerized real-time detection of colorectal neoplasms in a randomized study. Gastroenterology. 2020; 159: 512-520.e7.4. Krebs.Net. Colon cancer: statistics. January 2020. Available at: https://www.cancer.net/cancer-types/colorectal-cancer/statistics. Accessed January 22, 2021. View source version on businesswire.com: https: //www.businesswire.com/news/home/20211028005768/en/CONTACT: Noah Flack (602) 883-1300Noah.Flack@ctca-hope.comKEYWORD : ARIZONA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: ONCOLOGY HEALTH MEDICAL EQUIPMENT TECHNOLOGY HOSPITALS OTHER TECHNOLOGY SOFTWARE SOURCE: Cancer Treatment Centers of America (CTCA) Copyright Business Wire 2021.PUB: 10/28/2021 11:40 AM / DISC 28 / DISC: 11:41 http://www.businesswire.com/news/home/20211028005768/en Copyright Business Wire 2021.

[ad_2]